No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Bone Morphogenetic Protein Receptors, Type II
-
Calcium Channel Blockers / therapeutic use
-
Chromosomes, Human, Pair 2 / genetics
-
Endothelium, Vascular / pathology
-
Epoprostenol / administration & dosage
-
Epoprostenol / adverse effects
-
Epoprostenol / therapeutic use
-
Genetic Predisposition to Disease
-
Humans
-
Hypertension, Pulmonary* / classification
-
Hypertension, Pulmonary* / drug therapy
-
Hypertension, Pulmonary* / epidemiology
-
Hypertension, Pulmonary* / etiology
-
Hypertension, Pulmonary* / genetics
-
Hypertension, Pulmonary* / pathology
-
Muscle, Smooth, Vascular / pathology
-
Mutation
-
Prevalence
-
Protein Serine-Threonine Kinases / deficiency
-
Protein Serine-Threonine Kinases / genetics*
-
Survival Analysis
-
World Health Organization
Substances
-
Anticoagulants
-
Calcium Channel Blockers
-
Epoprostenol
-
Protein Serine-Threonine Kinases
-
BMPR2 protein, human
-
Bone Morphogenetic Protein Receptors, Type II